Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SUNESIS PHARMACEUTICALS INC | 150,000 | reported | 16 Mar 2023 | tx 26+494,656−75,064 |
| RIGEL PHARMACEUTICALS INC | 34,853 | reported | 17 Feb 2026 | tx 7+257,668−3,758 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Feb 2026 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 18,894 | 0.00 USD | |
| 10 Feb 2026 | TAX_WITHHOLDING | RIGEL PHARMACEUTICALS INC | 3,758 | 34.62 USD | |
| 15 Sept 2025 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 7,394 | 0.00 USD | deriv |
| 17 Mar 2025 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 9,375 | 0.00 USD | deriv |
| 29 Jan 2025 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 19,717 | 0.00 USD | |
| 29 Jan 2025 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 14,788 | 0.00 USD | deriv |
| 27 Mar 2024 | GRANT_AWARD | RIGEL PHARMACEUTICALS INC | 187,500 | 0.00 USD | deriv |
| 16 Mar 2023 | GRANT_AWARD | SUNESIS PHARMACEUTICALS INC | 150,000 | 0.00 USD | deriv |
| 25 Feb 2023 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 4,127 | 0.00 USD | |
| 27 Feb 2023 | SALE | SUNESIS PHARMACEUTICALS INC | 2,156 | 1.68 USD | |
| 25 Feb 2023 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 4,127 | 0.00 USD | deriv |
| 25 Nov 2022 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 4,127 | 0.00 USD | |
| 28 Nov 2022 | SALE | SUNESIS PHARMACEUTICALS INC | 2,116 | 2.72 USD | |
| 25 Nov 2022 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 4,127 | 0.00 USD | deriv |
| 26 Aug 2022 | SALE | SUNESIS PHARMACEUTICALS INC | 2,190 | 4.01 USD | |
| 25 Aug 2022 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 4,127 | 0.00 USD | |
| 25 Aug 2022 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 4,127 | 0.00 USD | deriv |
| 25 May 2022 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 4,127 | 0.00 USD | |
| 26 May 2022 | SALE | SUNESIS PHARMACEUTICALS INC | 2,154 | 1.90 USD | |
| 25 May 2022 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 4,127 | 0.00 USD | deriv |
| 17 Mar 2022 | GRANT_AWARD | SUNESIS PHARMACEUTICALS INC | 150,000 | 0.00 USD | deriv |
| 25 Feb 2022 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 4,127 | 0.00 USD | |
| 28 Feb 2022 | SALE | SUNESIS PHARMACEUTICALS INC | 2,395 | 2.78 USD | |
| 25 Feb 2022 | EXERCISE | SUNESIS PHARMACEUTICALS INC | 4,127 | 0.00 USD | deriv |
| 26 Nov 2021 | SALE | SUNESIS PHARMACEUTICALS INC | 1,950 | 4.80 USD |